Recombinant Streptokinase (Rsk) Council of Scientific & Industrial Research (CSIR)'s Second-Generation Clot Buster

Accessibility Controls

Implementing Organization

Council of Scientific & Industrial Research, Extra Mural Research Division (CSIR-EMR), India

Project Overview

This invention pertains to the Process for the production of recombinant streptokinase (Rsk) which is roughly ten times efficient than natural streptokinase. A facile process has been developed to manufacture a recombinant version of natural type streptokinase which is around ten times more efficient than natural streptokinase. Another advantage is its Cost effectiveness.

Related Research

View All

Quick Information

Thrust Areas

Life Sciences & Biotechnology

Status

Already Commercialised

Output

Status

Already Commercialised

Accessibility Controls

All Technologies